People with HIV were more likely to develop fatty liver disease if they took antiretroviral treatment that contains an integrase inhibitor or tenofovir alafenamide (TAF) Read More
People with HIV taking newer antiretrovirals at higher risk of fatty liver disease
Reading Time: < 1 minute